Mednet Logo

Do you recommend performing surveillance kidney allograft biopsies in your asymptomatic kidney transplant recipients?

Community PollStarted

Do the benefits of surveillance biopsies outweigh the risks?

39 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Nephrology · UCSF
Answered on

In general, I am a believer in management or surveillance biopsies. However, I also think there should be low threshold to forego the biopsy should it put the patient at increased risk, such as anticoagulation or intraperitoneal kidney. The other consideration is what is your plan for treating, or n...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · Dell Medical School
Answered on

Agree with both Drs. @Dr. First Last and @Dr. First Last on their assessment of the utility of using surveillance biopsies. The reality is that many transplant centers have outsourced their renal allograft biopsies to radiology/IR, and thus may not have the same degree of control over how and when b...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · University of Alabama Birmingham
Answered on

At our center, we do 6-month surveillance biopsies for all patients as standard of care. Our subclinical rejection rate is under 10%.

I think it is still a matter of controversy if surveillance biopsies help improve outcomes. Each center has to decide based on their patient demographics/outcomes and ...

Join for free or sign in to see the full answer